AMBEY — Ambey Laboratories Balance Sheet
0.000.00%
- IN₹990.39m
- IN₹1.38bn
- IN₹1.31bn
Annual balance sheet for Ambey Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2025 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
Standards: | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 5.12 | 2.89 | 10.2 | 17.6 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 73.8 | 90.8 | 37.9 | 483 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 200 | 243 | 275 | 865 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 155 | 241 | 242 | 382 |
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 446 | 559 | 576 | 1,272 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 219 | 216 | 203 | 396 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Total Other Liabilities | ||||
Total Funded Status | ||||
Total Liabilities | 525 | 369 | 340 | 509 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Unrealized Gain / Loss | ||||
Total Equity | -78.6 | 191 | 236 | 764 |
Total Liabilities & Shareholders' Equity | 446 | 559 | 576 | 1,272 |
Total Common Shares Outstanding |